Pirtobrutinib,Venetoclax,Rituximab
Eli Lilly,Roche,Abbvie
['leusm', 'venetoclax', 'cll', 'valent ,(-prevalent)', 'loxo', 'valent ,(-prevalent),(-equivalent),(-bivalent)']
#eha2023 poster presentation: matching-adjusted indirect comparison of a highly selective, non-covalent (reversible) btki vs. venetoclax continuous monotherapy in pts w/ relapsed/refractory cll previously treated w/ a covalent btki #leusm learn more here: 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK